Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

26 Mar 2014

Abstract excerpt

// Fares Al-Ejeh 1* , Mariska Miranda 1,2 , Wei Shi 1 , Peter T. Simpson 3 , Sarah Song 4 , Ana Cristina Vargas 3 , Jodi M. Saunus 3 , Chanel E. Smart 3 , Mythily Mariasegaram 3 , Adrian P. Wiegmans 1 , Georgia Chenevix-Trench 5 , Sunil R. Lakhani 3,6,7 , and Kum Kum Khanna 1,2* 1 Signal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Herston QLD 4006, Australia 2 The University of Queensland,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Cancer Cells and Metastasis
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24762669
DOI: 10.18632/oncotarget.1865

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancerPMID 24762669Read ↗

The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic ResponsivenessSemantic proximity Read ↗

The Molecular Landscape and Utility of Multiomic Analyses in Triple Negative Breast Cancer: Further Subtyping and Exploring Novel Biomarkers and Therapeutic TargetsSemantic proximity Read ↗

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Semantic proximity Read ↗

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read ↗

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity Read ↗

Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.Semantic proximity Read ↗

Clinical implications of molecular heterogeneity in triple negative breast cancer.Semantic proximity Read ↗

Triple-negative breast cancer and the need for new therapeutic targets.Semantic proximity Read ↗

Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.Semantic proximity Read ↗

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read ↗

Kinome expression profiling and prognosis of basal breast cancersSemantic proximity Read ↗

Quantitative proteomics analysis of triple-negative breast cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.